Macular dystrophy treatment in Turkey: what is macular dystrophy?
Macular dystrophy is a group of inherited eye diseases in which the macula, the small central part of the retina responsible for sharp vision, gradually loses function. People notice blurred or distorted central sight, trouble reading, difficulty with faces and colours, and a dark patch in the middle of their vision, while side vision usually stays. The best known types are Stargardt disease, Best vitelliform macular dystrophy, pattern dystrophy and cone-rod dystrophy. Most begin in childhood or early adult life, although some appear later. Because the cause is genetic, macular dystrophy is different from age-related macular degeneration, though the two can look similar on scans.
This guide is honest about what treatment can and cannot do today. It explains how the diagnosis is made, what care exists, what to be careful about, and what a second opinion in Turkey can offer. For the wider field see our eye treatments in Turkey.
Is there a cure for macular dystrophy?
Not at present. There is no approved treatment that restores the lost macular cells or stops most inherited macular dystrophies from progressing. Care focuses on confirming the exact type, protecting the retina where possible, treating complications that can be treated, and helping you use your remaining vision. A gene therapy exists for one rare inherited retinal disease caused by a fault in the RPE65 gene, but it is not a treatment for Stargardt or Best disease. Be cautious of any clinic that offers a cure, stem-cell injections or "reversal" for a fee outside a regulated clinical trial.
How is macular dystrophy diagnosed?
An accurate diagnosis shapes everything else. The retina specialist examines the back of the eye and usually uses several imaging tests: optical coherence tomography (OCT eye scan), fundus autofluorescence photographs that show stressed retinal cells, and sometimes fluorescein angiography. A visual field test, colour vision test and electroretinogram (ERG), which measures retinal electrical activity, may follow. Genetic testing can identify the gene involved, such as ABCA4 in Stargardt disease or BEST1 in Best disease, and helps with prognosis and family planning. See our guide to the retina department for the range of retinal services.
Which macular dystrophy treatments are used today?
Care is a mix of supportive steps. The table sets out the main approaches and their limits.
| Approach | Suits | Typical limits |
|---|---|---|
| Regular monitoring and imaging | Everyone with a confirmed diagnosis | Tracks change; does not alter the course |
| Light protection and lifestyle advice | Types where light or oxidative stress may play a role | Evidence is limited; advice is precautionary |
| Anti-VEGF injections | Types complicated by abnormal new vessels (for example Best disease or pattern dystrophy) | Treats the complication, not the dystrophy itself |
| Low vision aids and training | All types once reading or daily tasks are affected | Does not restore sight |
| Clinical trials | Selected patients meeting trial criteria | Experimental; no promise of benefit |
Can injections or surgery help in macular dystrophy?
Only in specific situations. Some dystrophies can lead to choroidal neovascularisation, in which fragile new blood vessels grow under the macula and leak. Injections of an anti-VEGF medicine into the eye can control this and protect vision, and the retina specialist decides whether they are right for you. They do not treat the underlying dystrophy. Surgery does not repair the macula; vitreoretinal operations are used for complications such as a macular hole or a detached retina and not for the dystrophy itself. Cataract surgery may help if a lens opacity adds to the blur.
What does the evidence say about vitamins, diet and light protection?
Ask your specialist before taking supplements. In Stargardt disease, specialists commonly advise against high-dose vitamin A supplements, since the disease is linked to a build-up of vitamin A by-products in the retina, and this is a point where family-doctor advice for general eye health can differ. Sunglasses and a hat reduce glare and may be recommended as a precaution. A diet rich in vegetables and oily fish suits general health, but there is no proof that it changes the course of an inherited macular dystrophy. Treat claims of a "reversing" diet or supplement with scepticism.
Macular dystrophy treatment cost in Turkey compared with the UK, US and Germany
There is no operation to price, so the costs are for the assessment and for an injection if one is needed. The ranges are approximate, not hospital quotes.
| Country | Full retinal work-up | One anti-VEGF injection |
|---|---|---|
| Turkey | €300 – €1,500 | €250 – €700 |
| United Kingdom | €600 – €2,500 | €600 – €1,300 |
| United States | €1,000 – €4,000 | €1,000 – €2,800 |
| Germany | €500 – €2,000 | €600 – €1,300 |
What changes the price: whether an ERG and genetic test are included, which injection drug is used, how many visits are needed and whether low vision assessment is added. Genetic testing is often priced separately by the laboratory. A package usually includes the consultation, imaging, and the injection if indicated; ask for each item in writing.
Who should consider a second opinion, and who should not?
A second opinion helps if your diagnosis is not confirmed by imaging and genetic tests, if you have sudden worsening or distortion that might signal a treatable complication, or if you want to know whether a trial might suit you. It is less useful for finding a cure that your own specialist has told you does not exist. It matters most to ask the new team to examine your existing scans and reports, since repeating every test can be unnecessary. Children should be seen by a paediatric retina team, with the parents present. If an eye turn accompanies the poor central sight, strabismus surgery addresses the alignment only, not the dystrophy.
Recovery, follow-up and daily life
An assessment needs no recovery, apart from blurred vision for a few hours after dilating drops. After an injection the eye may feel gritty for a day or two, and you may see floaters; severe pain, increasing redness or worsening vision needs urgent attention. Long-term care is regular follow-up, often every few months to yearly, and rehabilitation. Our guide to low vision rehabilitation describes aids and training that can help with reading and independence. A trip to Turkey for an assessment usually takes two to four days, and injections need a plan for repeat visits.
What results can you realistically expect?
A realistic aim is an accurate diagnosis, a clear explanation of the likely course, treatment of any treatable complication, and useful aids. Scans in photographs show retinal changes but cannot show how it feels to see. Vision may remain stable for years in some types and decline more quickly in others, and the pace is hard to predict for any one person. Honest clinics will not promise improvement, and they will tell you when a trial or a repeat test is worth considering.
What are the risks, and how do you choose a clinic?
Diagnostic tests carry very small risks: dilating drops can cause brief blurring and light sensitivity, and fluorescein dye can cause nausea or, rarely, an allergic reaction. Injections carry rare risks of eye infection, raised pressure, bleeding and retinal detachment, explained in leaflets from the NHS and the Royal College of Ophthalmologists. The larger risk is financial: unproven stem-cell or "regenerative" offers that are not part of a registered trial. Choose a retina specialist in a licensed eye hospital that offers OCT and autofluorescence, communicates in writing and shares its reports. Read how our process works and request a written plan through our free quote page. Questions to ask:
- Which tests will you do, and will you review my existing scans?
- Is genetic testing offered, and who explains the result?
- If an injection is needed, which drug and how many visits?
- What is included in the price?
- Do you offer anything outside a registered clinical trial, and on what evidence?
Hospitals with Eye Surgery in Turkey
Frequently asked questions
It is a group of inherited diseases, such as Stargardt and Best disease, in which the central retina gradually loses function. People notice blurred or distorted central vision, while side vision usually stays.
Not currently. There is no approved treatment that restores lost macular cells or stops most types from progressing. Care aims to confirm the type, treat complications and support remaining vision, and trials are ongoing.
Approximate ranges are €300 to €1,500 for a full retinal work-up in Turkey, against about €600 to €2,500 in the UK, with injections extra. The clinic confirms each item in a written quote.
Anti-VEGF injections can treat abnormal new vessels that sometimes develop in types such as Best disease. They address the complication, not the underlying dystrophy, and the retina specialist decides if they are right.
By an eye examination, OCT and autofluorescence imaging, and sometimes an ERG and visual field test. Genetic testing can identify the gene involved, such as ABCA4 in Stargardt disease.
Ask your specialist first. In Stargardt disease high-dose vitamin A supplements are usually avoided, and there is no proof that vitamins or diet reverse an inherited macular dystrophy.
Not as a routine treatment. Stem-cell and gene studies are experimental and run in registered clinical trials. Be wary of clinics selling regenerative treatment outside a trial.
Macular dystrophy affects central vision and usually leaves side vision, so total blindness is uncommon. How fast it progresses varies by type and person, and a specialist can explain the likely course.
Low vision rehabilitation provides magnifiers, lighting, software and training for reading and mobility. It does not restore sight, but it can help you keep independence and work.
A full assessment with imaging usually takes two to four days. If an injection is needed, ask how many follow-up visits to expect and whether they can be arranged near home.